Skip to content

Evaluation of administering levothyroxine in morning versus evening in Sari hypothyroid patients

Evaluation the effectiveness of administering levothyroxine in morning versus evening on thyroid factor number 4 and thyroid stimulating hormon in sari hypothyroid patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903223014N2
Enrollment
50
Registered
2011-04-10
Start date
2010-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypothyroidism. thyroid gland disorders

Interventions

Intervention 1: During the study 50 patients who are going to the endocrinology clinic of Sari for treating their hypothyroidism enter to the study. These people divided in two 25people group. During
Treatment - Drugs
Placebo
During the study 50 patients who are going to the endocrinology clinic of Sari for treating their hypothyroidism enter to the study. These people divided in two 25people group. During the first 2 mo
During the study 50 patients who are going to the endocrinology clinic of Sari for treating their hypothyroidism enter to the study. These people divided in two 25people group. Each group should tak

Sponsors

Mazandaran University of Medical Sciences, Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion: patients with hypothyroidism, up to 18 Exclusion: pregnant, GI problems, drugs which interact with levothyroxine

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
TSH. Timepoint: every 2 month. Method of measurement: with lab kit.;T4. Timepoint: every 2 months. Method of measurement: with lab kit.

Secondary

MeasureTime frame
Primary complaint. Timepoint: every 2 months. Method of measurement: request form.;Changing in weight. Timepoint: Every 2 month. Method of measurement: recuest form.;Efficacy of life. Timepoint: Every 2 month. Method of measurement: Recuest form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Sasanpour

Mazandaran University of Medical Sciences, Vice chancellor for research

sasanpoorneda@gmail.com+98 31 1234 6378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026